Page last updated: 2024-11-10

mycosubtiline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

mycosubtiline: antifungal agent isolated from Bacillus subtilis which is a mixture of homologous lipopeptides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3083700
SCHEMBL ID21303808
MeSH IDM0059477

Synonyms (8)

Synonym
pyrrolo(1,2-g)(1,4,7,10,13,16,19,22,25)nonaazacyclooctacosine, cyclic peptide deriv.
mycosubtiline
1392-60-5
mycosubtilin
3-[(3s,6s,13s,16r,19r,22r,25r,28s)-6,13,19,22-tetrakis(2-amino-2-oxoethyl)-16-(hydroxymethyl)-25-[(4-hydroxyphenyl)methyl]-10-(11-methyltridecyl)-2,5,8,12,15,18,21,24,27-nonaoxo-1,4,7,11,14,17,20,23,26-nonazabicyclo[26.3.0]hentriacontan-3-yl]propanamide
Q19361671
SCHEMBL21303808
DTXSID501028303
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (23.08)18.7374
1990's2 (5.13)18.2507
2000's13 (33.33)29.6817
2010's11 (28.21)24.3611
2020's4 (10.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]